• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13D filed by Sharps Technology Inc.

    2/13/26 4:15:01 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care
    Get the next $STSS alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    Sharps Technology, Inc.

    (Name of Issuer)


    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)


    82003F309

    (CUSIP Number)


    Brian Crist
    FalconX Holdings Limited, 1850 Gateway Drive, 6th Floor
    San Mateo, CA, 94404
    650-200-0698


    Justin Smith, Esq.
    Goodwin Procter LLP, 601 S., Figueroa St., Suite 4100
    Los Angeles, CA, 90017
    213-426-2649


    Leonard Wood, Esq.
    Goodwin Procter LLP, The NYT Building, 620 Eighth Avenue
    New York, NY, 10018
    212-459-7058

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    10/14/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    Solios, Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    10,665,460.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    10,665,460.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    10,665,460.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    15.9 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    (1) The number of shares in rows 7, 9, and 11 consists of (i) Cash Pre-Funded Warrants exercisable for 461,538 shares of Common Stock; (ii) Cryptocurrency Pre-Funded Warrants exercisable for 4,871,192 shares of Common Stock; (iii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock; and (iv) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock. Each of the foregoing warrants became exercisable upon receipt of stockholder approval on October 14, 2025. The Cash Pre-Funded Warrants and Cryptocurrency Pre-Funded Warrants are subject to a 9.99% beneficial ownership limitation that restricts exercise to the extent such exercise would result in Solios, Inc. ("Solios") beneficially owning more than 9.99% of the Issuer's outstanding Common Stock. Because the shares underlying the Cash Stapled Warrants and Cryptocurrency Stapled Warrants alone exceed such limitation, no shares issuable upon exercise of the Pre-Funded Warrants are included in the beneficial ownership of Solios as reported in Row 13 of the table. The Cash Stapled Warrants and Cryptocurrency Stapled Warrants are not subject to any beneficial ownership limitation and are exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Accordingly, the shares underlying such warrants are included in Solios's beneficial ownership. Solios may be deemed to beneficially own an aggregate of 5,332,730 shares of the Issuer's Common Stock, representing approximately 15.9% of the outstanding shares of Common Stock. (2) The percent of class set forth in row 13 was calculated based on 28,226,153 shares of the Issuer's Common Stock outstanding, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on October 23, 2025, and includes shares of Common Stock issuable upon exercise of (i) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock; and (ii) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock, each exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i).


    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    FalconX Alpha, Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    10,665,460.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    10,665,460.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    10,665,460.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    15.9 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    (1) The number of shares in rows 7, 9, and 11 consists of (i) Cash Pre-Funded Warrants exercisable for 461,538 shares of Common Stock; (ii) Cryptocurrency Pre-Funded Warrants exercisable for 4,871,192 shares of Common Stock; (iii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock; and (iv) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock. Each of the foregoing warrants became exercisable upon receipt of stockholder approval on October 14, 2025. The Cash Pre-Funded Warrants and Cryptocurrency Pre-Funded Warrants are subject to a 9.99% beneficial ownership limitation that restricts exercise to the extent such exercise would result in Solios, Inc. ("Solios"), together with its affiliates, beneficially owning more than 9.99% of the Issuer's outstanding Common Stock. Because the shares underlying the Cash Stapled Warrants and Cryptocurrency Stapled Warrants alone exceed such limitation, no shares issuable upon exercise of the Pre-Funded Warrants are included in the beneficial ownership of the Reporting Person as reported in Row 13 of the table. The Cash Stapled Warrants and Cryptocurrency Stapled Warrants are not subject to any beneficial ownership limitation and are exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Accordingly, the shares underlying such warrants are included in the Reporting Person's beneficial ownership. The Reporting Person may be deemed to beneficially own an aggregate of 5,332,730 shares of the Issuer's Common Stock, representing approximately 15.9% of the outstanding shares of Common Stock. (2) The percent of class set forth in row 13 was calculated based on 28,226,153 shares of the Issuer's Common Stock outstanding, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on October 23, 2025, and includes shares of Common Stock issuable upon exercise of (i) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock; and (ii) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock, each exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i).


    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    MNNC Capital Digital Asset Opportunities Master Fund LP
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    923,076.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    923,076.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    923,076.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    3.2 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    MNNC Capital Digital Opportunities BTC Master Fund LP
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    615,384.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    615,384.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    615,384.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    2.2 %
    14Type of Reporting Person (See Instructions)

    PN



    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    MNNC Capital GP LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    1,538,460.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    1,538,460.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    1,538,460.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.4 %
    14Type of Reporting Person (See Instructions)

    OO



    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    Monarch Digital, Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    1,538,460.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    1,538,460.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    1,538,460.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    5.4 %
    14Type of Reporting Person (See Instructions)

    CO



    SCHEDULE 13D

    CUSIP No.
    82003F309


    1 Name of reporting person

    FalconX Holdings Limited
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    AF
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    12,203,920.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    12,203,920.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    12,203,920.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    20.0 %
    14Type of Reporting Person (See Instructions)

    HC

    Comment for Type of Reporting Person:
    (1) The number of shares in rows 7, 9, and 11 consists of: (i) Cash Pre-Funded Warrants exercisable for 461,538 shares of Common Stock held by Solios, Inc. ("Solios"); (ii) Cryptocurrency Pre-Funded Warrants exercisable for 4,871,192 shares of Common Stock held by Solios; (iii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock held by Solios; (iv) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock held by Solios; (v) 461,538 shares of Common Stock held by MNNC Capital Digital Asset Opportunities Master Fund LP ("MNNC Master Fund"); (vi) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock held by MNNC Master Fund; (vii) 461,538 shares of Common Stock held by MNNC Capital Digital Opportunities BTC Master Fund LP ("MNNC BTC Master Fund"); (viii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock held by MNNC BTC Master Fund. Each of the foregoing warrants became exercisable upon receipt of stockholder approval on October 14, 2025. The Cash Pre-Funded Warrants and Cryptocurrency Pre-Funded Warrants are subject to a 9.99% beneficial ownership limitation that restricts exercise to the extent such exercise would result in the Reporting Person beneficially owning more than 9.99% of the Issuer's outstanding Common Stock. Because the shares underlying the Cash Stapled Warrants and Cryptocurrency Stapled Warrants alone exceed such limitation, no shares issuable upon exercise of the Pre-Funded Warrants are included in the beneficial ownership as reported in Row 13 of the table. The Cash Stapled Warrants and Cryptocurrency Stapled Warrants are not subject to any beneficial ownership limitation and are exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Accordingly, the shares underlying such warrants are included in the beneficial ownership and FalconX Holdings Limited may be deemed to beneficially own an aggregate of 6,871,190 shares of the Issuer's Common Stock, representing approximately 20.0% of the outstanding shares of Common Stock. (2) The percent of class set forth in row 13 was calculated based on 28,226,153 shares of the Issuer's Common Stock outstanding, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on October 23, 2025, and includes shares of Common Stock issuable upon exercise of (i) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock held by Solios; (ii) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock held by Solios; (iii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock held by MNNC Master Fund; and (iv) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock held by MNNC BTC Master Fund, each exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i).


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, par value $0.0001 per share
    (b)Name of Issuer:

    Sharps Technology, Inc.
    (c)Address of Issuer's Principal Executive Offices:

    105 Maxess Road, Suite 124, Melville, NEW YORK , 11747.
    Item 2.Identity and Background
    (a)
    This statement on Schedule 13D ("Schedule 13D") is filed by the entities listed below (collectively the "Reporting Persons"): (i) Solios, Inc., a Delaware corporation ("Solios"); (ii) FalconX Alpha, Inc., a Delaware corporation ("FalconX Alpha") and the sole stockholder of Solios, and a wholly owned direct subsidiary of FalconX Holdings; (iii) MNNC Capital Digital Asset Opportunities Master Fund LP, a Cayman Islands limited partnership ("MNNC Master Fund"); (iv) MNNC Capital Digital Opportunities BTC Master Fund LP, a Cayman Islands limited partnership ("MNNC BTC Master Fund", and together with the MNNC Master Fund, the "MNNC Funds"); (v) MNNC Capital GP LLC, a Cayman Islands limited liability company ("MNNC GP") and the general partner of the MNNC Funds; (vi) Monarch Digital, Inc., a Cayman Islands exempted company ("Monarch Digital"), which holds a majority of the voting equity interests in MNNC GP and is a wholly owned direct subsidiary of FalconX Holdings; and (vii) FalconX Holdings Limited, a Cayman Islands exempted company ("FalconX Holdings"). The Reporting Persons have entered into a joint filing agreement, a copy of which is attached hereto as Exhibit 99.1.
    (b)
    The principal business address of Solios, FalconX Alpha, Monarch Digital, and FalconX Holdings is 1850 Gateway Drive, 6th Floor, San Mateo, CA 94404. The principal business address of MNNC Funds and MNNC GP is Signal House, Fairbanks Road, P.O.Box CEC-1, Grand Cayman KY1-9012 Cayman Islands. The MNNC Funds are the direct holders of certain of the securities reported in this Schedule 13D. MNNC Capital Digital Opportunities BTC Fund LP, a Cayman Islands limited partnership, is the sole limited partner of MNNC BTC Master Fund, and MNNC Capital Digital Asset Opportunities Onshore Fund LP, a Delaware limited partnership, and MNNC Capital Digital Asset Opportunities Fund LP, a Cayman Islands limited partnership, are the sole limited partners of MNNC Master Fund.
    (c)
    Each of the Reporting Persons is principally engaged in the business of investing in securities.
    (d)
    During the last five years, none of the Reporting Persons or, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A attached hereto have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
    (e)
    During the last five years, none of the Reporting Persons or, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A attached hereto have been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
    (f)
    See Item 2(a).
    Item 3.Source and Amount of Funds or Other Consideration
     
    The securities of the Issuer reported herein were acquired by the Reporting Persons pursuant to a private placement transaction (the "Private Placement") described in the Issuer's Current Report on Form 8-K filed on August 25, 2025. Solios purchased (i) Cash Pre-Funded Warrants exercisable for 461,538 shares of Common Stock, (ii) Cryptocurrency Pre-Funded Warrants exercisable for 4,871,192 shares of Common Stock, (iii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock, and (iv) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock. Each of the foregoing warrants became exercisable upon receipt of stockholder approval on October 14, 2025. Solios purchased the Cash Pre-Funded Warrants and Cryptocurrency Pre-Funded Warrants at a price of $6.4999 per warrant, each exercisable for one share of Common Stock for a nominal exercise price. The Cash Stapled Warrants and Cryptocurrency Stapled Warrants are exercisable for one share of Common Stock at an exercise price of $9.75 per warrant. The consideration for such warrants consisted of cash and/or cryptocurrency and digital assets, as applicable, as provided in the applicable transaction documents. Any exercise price payable upon exercise of the Stapled Warrants will be paid using Solios's working capital or other available funds. MNNC Master Fund purchased shares of Common Stock at a purchase price of $6.50 per share and received Cash Stapled Warrants exercisable for additional shares of Common Stock. As of October 14, 2025, MNNC Master Fund beneficially owned 461,538 shares of Common Stock and held Cash Stapled Warrants exercisable for an additional 461,538 shares of Common Stock. The Cash Stapled Warrants became exercisable upon receipt of stockholder approval on October 14, 2025. No separate consideration was paid for the Cash Stapled Warrants, which were issued in connection with the purchase of Common Stock. MNNC BTC Master Fund purchased shares of Common Stock at a purchase price of $6.50 per share and received Cash Stapled Warrants exercisable for additional shares of Common Stock. As of October 14, 2025, MNNC BTC Master Fund beneficially owned 307,692 shares of Common Stock and held Cash Stapled Warrants exercisable for an additional 307,692 shares of Common Stock. The Cash Stapled Warrants became exercisable upon receipt of stockholder approval on October 14, 2025. No separate consideration was paid for the Cash Stapled Warrants, which were issued in connection with the purchase of Common Stock. The aggregate consideration paid by Solios, MNNC Master Fund and MNNC BTC Master Fund for the securities acquired in the Private Placement was approximately $45.7 million, which was derived solely from their respective working capital. No funds were borrowed or obtained for the purpose of acquiring the securities reported in this Schedule 13D.
    Item 4.Purpose of Transaction
     
    The securities were acquired for investment purposes. The Reporting Persons entered into the transaction to obtain an equity position in the Issuer and exposure to the Issuer's business and growth prospects, including through the potential exercise of the warrants described above. The Reporting Persons may, from time to time, depending on market conditions, the Issuer's performance, business prospects, and other factors, engage in discussions with management or the board of directors of the Issuer regarding the Issuer's business, financial condition, operations, or strategic plans. The Reporting Persons may also evaluate their investment and take such actions as they deem appropriate, which may include acquiring additional securities of the Issuer, exercising warrants, disposing of some or all of their securities, or otherwise modifying their investment position. Except as described in this Schedule 13D, the Reporting Persons do not have any plans or proposals that relate to or would result in: (i) any extraordinary corporate transaction involving the Issuer; (ii) any sale or transfer of a material amount of the Issuer's assets; (iii) any change in the present board of directors or management of the Issuer; (iv) any material change in the Issuer's capitalization or dividend policy; (v) any other material change in the Issuer's business or corporate structure; (vi) any changes in the Issuer's charter or bylaws; or (vii) causing the Issuer's securities to be delisted from a national securities exchange or cease to be registered under the Securities Exchange Act of 1934 ("Act"). The foregoing description of the Reporting Persons' purposes and intentions is subject to change at any time based on market conditions or other factors.
    Item 5.Interest in Securities of the Issuer
    (a)
    Unless otherwise indicated, the percentage ownership calculations below are based on 28,226,153 shares of the Issuer's Common Stock outstanding, as reported in the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on October 23, 2025, and, with respect to each reporting person, include shares of Common Stock issuable upon exercise of warrants exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Solios held the following securities of the Issuer: (i) Cash Pre-Funded Warrants exercisable for 461,538 shares of Common Stock; (ii) Cryptocurrency Pre-Funded Warrants exercisable for 4,871,192 shares of Common Stock; (iii) Cash Stapled Warrants exercisable for 461,538 shares of Common Stock; and (iv) Cryptocurrency Stapled Warrants exercisable for 4,871,192 shares of Common Stock. Each of the foregoing warrants became exercisable upon receipt of stockholder approval on October 14, 2025. The Cash Pre-Funded Warrants and Cryptocurrency Pre-Funded Warrants are subject to a 9.99% beneficial ownership limitation that restricts exercise to the extent such exercise would result in Solios beneficially owning more than 9.99% of the Issuer's outstanding Common Stock. Because the shares underlying the Cash Stapled Warrants and Cryptocurrency Stapled Warrants alone exceed such limitation, no shares issuable upon exercise of the Pre-Funded Warrants are included in the beneficial ownership of Solios as reported in Row 13 of the table. The Cash Stapled Warrants and Cryptocurrency Stapled Warrants are not subject to any beneficial ownership limitation and are exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Accordingly, the shares underlying such warrants are included in Solios's beneficial ownership. Solios may be deemed to beneficially own an aggregate of 5,332,730 shares of the Issuer's Common Stock, representing approximately 15.9% of the outstanding shares of Common Stock. MNNC Master Fund beneficially owned 461,538 shares of the Issuer's Common Stock. MNNC Master Fund also held Cash Stapled Warrants exercisable for 461,538 shares of Common Stock. The Cash Stapled Warrants became exercisable upon receipt of stockholder approval on October 14, 2025, are not subject to any beneficial ownership limitation, and are exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Accordingly, the shares underlying the Cash Stapled Warrants are included in MNNC Master Fund's beneficial ownership. MNNC Capital Digital Asset Opportunities Master Fund, LP may be deemed to beneficially own an aggregate of 923,076 shares of the Issuer's Common Stock, representing approximately 3.2% of the outstanding shares of Common Stock. MNNC BTC Master Fund beneficially owned 307,692 shares of the Issuer's Common Stock. MNNC BTC Master Fund also held Cash Stapled Warrants exercisable for 307,692 shares of Common Stock. The Cash Stapled Warrants became exercisable upon receipt of stockholder approval on October 14, 2025, are not subject to any beneficial ownership limitation, and are exercisable within 60 days for purposes of Rule 13d-3(d)(1)(i). Accordingly, the shares underlying the Cash Stapled Warrants are included in MNNC BTC Master Fund's beneficial ownership. MNNC BTC Master Fund may be deemed to beneficially own an aggregate of 615,384 shares of the Issuer's Common Stock, representing approximately 2.2% of the outstanding shares of Common Stock. FalconX Alpha, as the sole stockholder of Solios, may be deemed to beneficially own the securities reported herein as directly owned by Solios. MNNC GP, as the general partner of the MNNC Funds, may be deemed to beneficially own the securities reported herein as indirectly beneficially owned by the MNNC Funds. Monarch Digital, as the holder of a majority of the voting equity of MNNC GP, may be deemed to beneficially own the securities reported herein as indirectly beneficially owned by MNNC GP. FalconX Holdings, as the sole stockholder of each of FalconX Alpha and Monarch Digital, may be deemed to beneficially own the securities reported herein as indirectly beneficially owned by each of FalconX Alpha and Monarch Digital.
    (b)
    The information set forth in rows (7) through (10) of the cover pages and Item 5(a) of this Schedule 13D is incorporated by reference into this Item 5(b).
    (c)
    Except as set forth in Item 3 of this Schedule 13D, the Reporting Persons have not effected any transactions in Common Stock within last 60 days.
    (d)
    Except as described herein, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities covered by this statement.
    (e)
    Not applicable.
    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
     
    The securities of the Issuer reported in this Schedule 13D were acquired by the Reporting Persons pursuant to a Cash Securities Purchase Agreement or a Cryptocurrency Securities Purchase Agreement, each dated on or about August 25, 2025, entered into between the Issuer and certain accredited investors, including certain of the Reporting Persons, in connection with the Private Placement, as described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 25, 2025 (the "Securities Purchase Agreements"). As described in the Issuer's Form 8-K and Item 5 of this Schedule 13D, (i) pursuant to the Securities Purchase Agreements and related transaction documents, the Issuer issued to certain of the Reporting Persons shares of Common Stock, Cash Pre-Funded Warrants, Cash Stapled Warrants, Cryptocurrency Pre-Funded Warrants, and Cryptocurrency Stapled Warrants, each of which warrants are exercisable for shares of the Issuer's Common Stock on the terms and subject to the conditions set forth therein, and (ii) the Pre-Funded Warrants contain beneficial ownership limitation provisions that restrict exercise to the extent such exercise would result in the holder beneficially owning more than a specified percentage of the Issuer's outstanding Common Stock. The Issuer also entered into a Registration Rights Agreement with the purchasers in the Private Placement, including the Reporting Persons, pursuant to which the Issuer agreed to file and maintain the effectiveness of one or more registration statements covering the resale of the shares of Common Stock issued or issuable upon exercise of the warrants issued in the Private Placement, subject to the terms and conditions set forth therein. Other than the agreements and arrangements described above, and the Joint Filing Agreement among the Reporting Persons filed as an exhibit to this Schedule 13D, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between any of the Reporting Persons and any other person with respect to any securities of the Issuer, including, without limitation, any agreements concerning the transfer or voting of any securities of the Issuer, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.
    Item 7.Material to be Filed as Exhibits.
     
    Exhibit 99.1 Joint Filing Agreement, dated as of February 13, 2026, by and among the Reporting Persons. Exhibit 4.1 Form of Cash Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Issuer's Current Report on Form 8-K filed on August 25, 2025). Exhibit 4.2 Form of Cryptocurrency Pre-Funded Warrant (incorporated by reference to Exhibit 4.2 to the Issuer's Current Report on Form 8-K filed on August 25, 2025). Exhibit 4.3 Form of Cash Stapled Warrant (incorporated by reference to Exhibit 4.3 to the Issuer's Current Report on Form 8-K filed on August 25, 2025). Exhibit 4.4 Form of Cryptocurrency Stapled Warrant (incorporated by reference to Exhibit 4.4 to the Issuer's Current Report on Form 8-K filed on August 25, 2025). Exhibit 10.1 Form of Cash Securities Purchase Agreement, dated as of August 25, 2025, by and among Sharps Technology, Inc. and each Purchaser (as defined therein) (incorporated by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed on August 25, 2025). Exhibit 10.2 Form of Cryptocurrency Securities Purchase Agreement, dated as of August 25, 2025, by and among Sharps Technology, Inc. and each Purchaser (as defined therein) (incorporated by reference to Exhibit 10.2 to the Issuer's Current Report on Form 8-K filed on August 25, 2025). Exhibit 10.3 Form of Registration Rights Agreement, dated as of August 25, 2025, by and among Sharps Technology, Inc. and each Holder (as defined therein) (incorporated by reference to Exhibit 10.3 to the Issuer's Current Report on Form 8-K filed on August 25, 2025).

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Solios, Inc.
     
    Signature:/s/ Matthew Whaley
    Name/Title:Matthew Whaley, its Vice President, Treasurer
    Date:02/13/2026
     
    FalconX Alpha, Inc.
     
    Signature:/s/ Matthew Whaley
    Name/Title:Matthew Whaley, its Vice President, Treasurer
    Date:02/13/2026
     
    MNNC Capital Digital Asset Opportunities Master Fund LP
     
    Signature:/s/ Shiliang Tang
    Name/Title:Shiliang Tang, its director
    Date:02/13/2026
     
    MNNC Capital Digital Opportunities BTC Master Fund LP
     
    Signature:/s/ Shiliang Tang
    Name/Title:Shiliang Tang, its director
    Date:02/13/2026
     
    MNNC Capital GP LLC
     
    Signature:/s/ Shiliang Tang
    Name/Title:Shiliang Tang, its director
    Date:02/13/2026
     
    Monarch Digital, Inc.
     
    Signature:/s/ Ben Grigus
    Name/Title:Ben Grigus, its Senior Director, Corporate Development
    Date:02/13/2026
     
    FalconX Holdings Limited
     
    Signature:/s/ Brian Crist
    Name/Title:Brian Crist, its Secretary
    Date:02/13/2026
    Get the next $STSS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STSS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STSS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sharps Technology and BitGo Announce Collaboration to Advance Solana Treasury Strategy

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana (SOL) digital asset treasury strategy, and BitGo Bank & Trust, National Association ("BitGo"), the digital asset infrastructure company, today announced a strategic collaboration under which STSS will expand and further institutionalize its Solana treasury strategy through BitGo's services. As part of this arrangement, STSS intends to utilize BitGo's institutional-grade qualified custody through its OCC regulated entity, BitGo Bank & Trust, National Association. In addition, STSS intends to leverage BitGo's Solana staking validator to earn com

    2/5/26 7:00:00 AM ET
    $BTGO
    $STSS
    Finance: Consumer Services
    Finance
    Medical/Dental Instruments
    Health Care

    Sharps Technology Reports Strong Solana Staking Income

    NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. ("STSS" or the "Company"), a medical device company implementing a Solana-based digital asset treasury strategy, today issued an update on its treasury and recent operational highlights. Treasury Updates Staking: Since inception, STSS's validator partners have generated ~7% gross annual percentage yield (APY) before fees, outperforming the Solana network average. Nearly all of the Company's SOL holdings are currently staked.Balance Sheet: STSS continues to maintain sufficient operating capital and has no corporate debt. Recent Operational Highlights In January, STSS announced a lock-up agreement with its Strategic Advi

    1/26/26 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025

    NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP ("SRFC") reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm's strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions. In October of 2025, for the fifth consecutive quarter, SRFC was ranked first in the nation for issuer counsel among securities law firms in Placement

    1/20/26 8:00:00 AM ET
    $EMIS
    $NCRA
    $SOUL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples

    $STSS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ruemler Timothy James increased direct ownership by 294% to 40,218 units (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:45:47 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Crescenzo Andrew R. bought $256,400 worth of Option (40,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:34 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Director Monroe Jason L. bought $512,800 worth of Option (80,000 units at $6.41) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    8/26/25 9:24:36 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Sharps Technology Inc.

    SCHEDULE 13D - Sharps Technology Inc. (0001737995) (Subject)

    2/13/26 4:15:01 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Sharps Technology Inc.

    EFFECT - Sharps Technology Inc. (0001737995) (Filer)

    2/2/26 12:15:19 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Sharps Technology Inc.

    SCHEDULE 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    1/23/26 6:09:54 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Falconx Holdings Ltd sold $1,490,755 worth of shares (769,320 units at $1.94) and exercised 461,538 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    2/13/26 4:45:04 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    New insider Falconx Holdings Ltd claimed ownership of 769,230 shares (SEC Form 3)

    3 - Sharps Technology Inc. (0001737995) (Issuer)

    2/13/26 4:10:05 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Large owner Saba Capital Management, L.P. sold $86,371 worth of shares (37,182 units at $2.32) (SEC Form 4)

    4 - Sharps Technology Inc. (0001737995) (Issuer)

    1/20/26 5:55:14 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Financials

    Live finance-specific insights

    View All

    Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

    NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Funded from the Company's recent PIPE equity raise, Sharps Technology now holds over 2 million SOL, creating a SOL treasury currently valued north of $400M. Sharps Technology intends to provide regular updates on its SOL holdings and performan

    9/2/25 7:00:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (NASDAQ:SNGX) and Sharps Technology Inc. (NASDAQ:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Soligenix: https://www.redchip.com/assets/access/sngx_accessSharps Technology: https://www.redchip.com/assets/access/stss_accessIn an exclusive interview, Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix, appears on the RedChip Small Stocks Big Money™ show on B

    6/7/24 9:00:00 AM ET
    $SNGX
    $STSS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQ:STSS), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and American Resources Corp. (NASDAQ:AREC) on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Sharps Technology: https://www.redchip.com/assets/access/stss_accessReviva Pharmaceuticals: https://www.redchip.com/assets/access/rvph_accessAmerican Resources Corp: https://www.redchip.com/assets/access/arec_accessAbout The RedChip

    9/29/23 9:00:00 AM ET
    $AREC
    $RVPH
    $STSS
    Coal Mining
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STSS
    Leadership Updates

    Live Leadership Updates

    View All

    Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

    NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ:STSS) (NASDAQ:STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is working to create new sales and distribution opportunities through the addition of new North American 3PL partnerships to expand its reach into the global healthcare market. These additional third-party logistics partnerships, along with a developing alliance with Roncadelle Operations, a driving force in the development of safe, novel medical drug delivery devices, would combine the strengths and capabilities of the two companies to develop, market and distribute unique dru

    2/16/24 2:42:54 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales

    Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its specialty smart safety syringe products to the market Product qualification and sales initiatives underway as company prepares for U.S. commercial operations NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, is pleased to announce the appointment of Ben Scheu as Senior Director of Sales to lead commercial operations as the Company prepares to launch products to the market.

    7/12/23 8:33:00 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Sharps Technology Appoints Justin Page as Vice President of Technical Operations

    NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the "Company", "Sharps") (NASDAQ: "STSS" and "STSSW"), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, appoints Justin Page as Vice President of Technical Operations. In his role, Mr. Page will be responsible for managing all aspects of Sharps' engineering operations. His primary focus will be to provide the leadership and technical expertise to support the prefillable syringe collaboration with Nephron Pharmaceuticals at the InjectEZ facility. These efforts will include the support for the injection molding of the specialty components and the high speed assembl

    2/9/23 9:21:23 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    $STSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    11/13/24 4:50:17 PM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sharps Technology Inc.

    SC 13G/A - Sharps Technology Inc. (0001737995) (Subject)

    10/9/24 9:01:14 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Sharps Technology Inc.

    SC 13G - Sharps Technology Inc. (0001737995) (Subject)

    2/14/24 11:14:11 AM ET
    $STSS
    Medical/Dental Instruments
    Health Care